Clinical trial
Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.
NCT04942119 is registered in ClinicalTrials.gov with United Arab Emirates University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.
- Lead sponsor
- United Arab Emirates University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2021
- Completion date
- August 1, 2022
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic kidney disease, magnesium deficiency, potassium imbalance